Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based diagnostics and services company Metabolon has appointed Edward Erickson to its board of directors.
Subscribe to our email newsletter
Mr Erickson is a board member, advisor and consultant to several life science companies and venture capital firms. Mr Erickson has extensive experience in the medical products industry having served as president, CEO or as director of over a dozen such companies, four of which successfully completed IPOs during his tenure.
Mr Erickson has received his BS and MS degrees from the Illinois Institute of Technology and an MBA from the Harvard Business School.
John Ryals, president and CEO of Metabolon, said: “Ed brings extensive experience in commercializing diagnostic products to our team at a time when we are moving our diagnostic offerings in diabetes (Quantose) and prostate cancer (Prostarix) into development. We are excited to have Ed join the Metabolon board to help us bring these new offerings to the market.”